The effect of predilation on the incidence of the no/slow-reflow phenomenon in patients with acute coronary syndrome with ST segment elevation
- Authors: Sazanov GV1,2, Belokon' OS1,2
-
Affiliations:
- Stavropol Regional Clinical Hospital
- Stavropol State Medical University
- Issue: Vol 101, No 2 (2020)
- Pages: 284-288
- Section: Clinical experiences
- URL: https://bakhtiniada.ru/kazanmedj/article/view/21228
- DOI: https://doi.org/10.17816/KMJ2020-284
- ID: 21228
Cite item
Full Text
Abstract
Aim. To assess the effect of balloon predilation on the incidence of no/slow-reflow complication during percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI).
Methods. We analyzed the experience of the department of endovascular diagnostic and treatment methods of the Stavropol Regional Clinical Hospital for endovascular surgical treatment of patients with STEMI, including after thrombolytic therapy (TLT). The study included 721 patients admitted to the hospital within the first 12 hours from the moment of the first contact with a medical staff. For the study, patients were divided into 2 comparable groups according to the gradation scale TIMI (Thrombolysis in myocardial infarction), comparable the patients' gender, age and other characteristics. Each of the groups also was divided into 2 subgroups according to performing predilation. The study also analyzed the correlation between patients' mortality and existence of the no/slow-reflow phenomenon.
Results. The lowest incidence of the no/slow-reflow phenomenon was in groups in which predilation before stent implantation was not performed. In the group where the blood flow was higher than TIMI 0, the occurrence rate of the no/slow-reflow phenomenon was 7.2 times higher in group with predilation. In the group where the artery was occluded, the risk of the phenomenon during predilation was 3.6 times higher than in group with the “tracking” method. The risk of mortality in patients with no/slow-reflow phenomenon was 3.9 times higher.
Conclusion. In carrying out the percutaneous coronary intervention, the most preferable is the refusal to perform predilation if there is an appropriate technical feasibility; it is recommended for patients with a blood flow level TIMI 0 to draw a balloon catheter for an occlusion site, which may allow antegrade blood flow to be achieved.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
G V Sazanov
Stavropol Regional Clinical Hospital; Stavropol State Medical University
Author for correspondence.
Email: mc_sagr@mail.ru
Russian Federation, Stavropol, Russia; Stavropol, Russia
O S Belokon'
Stavropol Regional Clinical Hospital; Stavropol State Medical University
Email: mc_sagr@mail.ru
Russian Federation, Stavropol, Russia; Stavropol, Russia
References
- Rentgenehndovaskulyarnaya khirurgiya. Natsionalʹnoe rukovodstvo. V 4 t. (X-ray endovascular surgery. National leadership. In 4 Vol.). Ed. by B.G. Alekyana. Vol. 2. M.: Litterra. 2017; 399–426. (In Russ.)
- Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur. Heart J. 2001; 22: 729–739. DOI: 10,1053/euhj.2000.2172.
- Yip H.K., Chen M.C., Chang H.W. et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon. Chest. 2002; 122 (4): 1322–1332. doi: 10.1378/chest.122.4.1322.
- Koval’ M. “No-reflow” phenomenon — a fly in the ointment of revascularization. Medicine Review. 2008; (5): 32–36. (In Russ.)
- Niccoli G., Burzotta F., Galiuto L. et al. Myocardial no-reflow in humans. J. Am. Coll. Cardiol. 2009; 54: 281–292. doi: 10.1016/j.jacc.2009.03.054.
- Iskhakov M.M., Tagirov D.R., Gazizov N.V. et al. “No-reflow” phenomenon: clinical aspects of reperfusion failure. Kazanskiy meditsinskiy zhurnal. 2015; 96 (3): 391–396. (In Russ.) doi: 10.17750/KMJ2015-391.
- Fischell T.A. Pharmaceutical interventions for the management of no-reflow. J. Invasive Cardiol. 2008; 20 (7): 374–379. PMID: 18599901.
- Ibanez B., James S., Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018; 39: 119–177. doi: 10.1093/eurheartj/ehx393.
- Rezkalla S.H., Kloner R.A. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Cath. Cardiovasc. Interv. 2008; 72 (7): 950–957. doi: 10.1002/ccd.21715.
- Henriques J., Zijlstra F., Ottervanger J. et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur. Heart J. 2002; 23: 1112–1117. doi: 10.1053/euhj.2001.3035.
- Neumann F.-J., Gick M. Direct stenting in ST-elevation myocardials infarction: convenient, but not improving outcomes. Eur. Heart J. 2018; 39 (26): 2480–2483. doi: 10.1093/eurheartj/ehy353.
- Jolly S., Cairns J., Yusuf S. et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N. Engl. J. Med. 2015; 372: 1389–1398. doi: 10.1056/NEJMoa1415098.
- Fröbert O., Lagerqvist B., Olivecrona G.K. et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N. Engl. J. Med. 2013; 369: 1587–1597. doi: 10.1056/NEJMoa1308789.
- Windecker S., Kolh P., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014; 35: 2541–2619. doi: 10.1093/eurheartj/ehu278.
- Dziewierz A., Siudak Z., Rakowski T. et al. Impact of direct stenting on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry). Catheter. Cardiovasc. Interv. 2014; 84 (6): 925–931. doi: 10.1002/ccd.25266.
- Isik T., Ayhan E., Uyarel H. et al. A comparison of direct versus conventional stenting in patients undergoing primary angioplasty for ST-elevation myocardial infarction. Coron. Artery Dis. 2012; 23: 348–353. doi: 10.1097/MCA.0b013e3283548862.
- Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 2006; 3: 499–506. doi: 10.1038/ncpcardio0632.
- Lorenzo A., Xavier V., Hung Q. et al. Direct stenting versus pre-dilation in ST-elevation myocardial infarction: A systematic review and meta-analysis. J. Interv. Cardiol. 2015; 28 (2): 119–131. doi: 10.1111/joic.12190.
- Ndrepepa G., Tiroch K., Fusaro M. et al. Five year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2010; 55: 2383–2389. doi: 10.1016/j.jacc.2009.12.054.
- Choo E., Kim P., Chang K.Y. et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron. Artery Dis. 2014; 25 (5): 392–398. doi: 10.1097/MCA.0000000000000108.
Supplementary files
